Canada: Life Sciences, Biotechnology & Nanotechnology

Can an employer limit drug plan reimbursement to only the lowest-cost generic version of a prescribed medication if the collective bargaining agreement...

In the first PMNOC decision of the year, Justice Furlanetto upheld the validity of claims 1 and 2 of Alexion's patent no. 2,645,810 which is directed to the antibody...

On May 1, 2025, the Ontario Attorney General introduced Bill 10, titled the "Protect Ontario Through Safer Streets and Stronger Communities Act, 2025,". The Bill is intended to enhance public safety.

Le projet de loi 83, Loi favorisant l'exercice de la médecine au sein du réseau public de la santé et des services sociaux...

In 2024, Osler represented 160 clients on preferred share financings — more than in any other year reflected in the Deal Points Report. Notwithstanding this data point...

In the first PMNOC decision of the year, Justice Furlanetto upheld the validity of claims 1 and 2 of Alexion's patent no. 2,645,810 which is directed to the antibody...

As part of its commitment outlined in the 2024 Ontario Economic Outlook and Fiscal Review, the Government of Ontario is moving forward with the new licensing framework...

Le projet de loi 83, Loi favorisant l'exercice de la médecine au sein du réseau public de la santé et des services sociaux...

In 2024, Osler represented 160 clients on preferred share financings — more than in any other year reflected in the Deal Points Report. Notwithstanding this data point...

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.